Closed · W81XWH-15-PRORP-OCRCA · CFDA 12.420 · Discretionary
DoD Orthopaedic Care and Rehabilitation Consortium Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- December 8, 2015
- Close date
- 1
- Expected awards
The verdict
DoD Orthopaedic Care and Rehabilitation Consortium Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 1
- expected award
- 12.420
- CFDA program
Archived opportunity record
DoD Orthopaedic Care and Rehabilitation Conso… is closed (last close December 8, 2015). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed December 8, 2015
Est. Total Funding
$18,000,000
Expected Awards
1
Instrument
Grant
Description
The PRORP OCRCA mechanism is being offered for the first time in FY15. The PRORP OCRCA is intended to support the establishment of a Consortium that consists of multiple organizations and individuals collaboratively working on clinical studies that are focused on improving both acute care treatment outcomes and functional, long-term rehabilitation outcomes of severe musculoskeletal injuries commonly associated with military combat or combat-related activities. The Consortium will consist of a single Coordinating Center in collaboration with multiple military treatment facilities (MTFs) (required) and non-military Clinical Study Sites (encouraged). The Government anticipates that applicants will assemble an expert team from multiple institutions, including, but not limited to, academia, MTFs, other Government agencies, clinical research institutions, industry partners, and not-for-profit enterprises to satisfy the objectives of this Program Announcement/Funding Opportunity. It is expected that relevant clinical outcomes will require longitudinal evaluations to optimize recovery and restoration of function. At the end of the performance period, it is anticipated that the awardee will establish a strong infrastructure for continuing clinical studies on combat-relevant musculoskeletal injuries and produce products (information, practice guidelines, validated techniques, or devices) that result in changes to, or validation of, current clinical practices that lead to better outcomes for injured Service members, U.S. Veterans, and civilians. All projects should develop a procurement cost estimate for successful treatments so that the military and civilian medical community can conduct a cost-benefit analysis with current practice alternatives, as well as distinguish the optimal cost-effective treatments. Projects must be relevant to the military, have well-defined objectives, control for confounding variables, have a patient population that will allow for an appropriately robust sample size at each Site, be of high quality, and be capable of producing results that are likely to change practice. Studies involving non-military patient populations must describe how they simulate the targeted population (i.e., Armed Forces and/or the U.S. Veteran population). While large, randomized, controlled clinical studies are expected to be part of this multi-institutional Consortium effort, small randomized or pilot clinical trials and observational prospective studies to develop metrics or provide proof of principle to inform future clinical studies are also appropriate. All projects shall be limited to clinical research and clinical trials. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. The term “human subjects” is used in this Program Announcement/Funding Opportunity to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. Clinical research encompasses studies in which individuals are observed or those where certain outcomes are measured. For more information on how to distinguish clinical research from clinical trials, see the Human Subject Resource Document at https://ebrap.org/eBRAP/public/Program.htm. Animal studies are excluded from consideration. The Coordinating Center must apply to this Program Announcement/Funding Opportunity through a single application, and may also serve as a Study Site. The PRORP OCRCA resulting from this Program Announcement/Funding Opportunity will be issued as a cooperative agreement between the recipient (Coordinating Center) and the Government. The Government will have substantial involvement in the Consortium through a Government Steering Committee (GSC) and U.S. Army Medical Research and Materiel Command (USAMRMC) staff interactions with the Consortium. The GSC will review research priorities and make recommendations to the Grants Officer’s Representative (GOR) for the GOR’s consideration, with ultimate approval decisions made by the USAMRAA Grants Officer (GO). Award funds will be used to support the Coordinating Center’s efforts as well as Consortium-associated studies at the Clinical Study Sites. The Coordinating Center will provide management and funding for the Clinical Study Sites through the appropriate subaward or other instrument.
Catch-all / unrestricted eligibility mark · W81XWH-15-PRORP-OCRCA
Grants.gov marks DoD Orthopaedic Care and Rehabilitation Conso… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk 301-682-5507
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Orthopaedic Care and Rehabilitation Conso… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |